Canada Pension Plan Investment Board bought a new stake in shares of The Allstate Corporation (NYSE:ALL - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 790,255 shares of the insurance provider's stock, valued at approximately $188,033,000. Canada Pension Plan Investment Board owned approximately 0.31% of Allstate at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Legal & General Group Plc acquired a new position in shares of Allstate during the 2nd quarter worth approximately $455,302,000. The Manufacturers Life Insurance Company acquired a new stake in Allstate during the 2nd quarter valued at $42,409,000. Van Hulzen Asset Management LLC purchased a new position in Allstate during the second quarter worth $728,000. Veratis Advisors Inc. purchased a new position in Allstate during the second quarter worth $764,000. Finally, Fiduciary Financial Advisors acquired a new position in shares of Allstate in the second quarter worth $42,000. Hedge funds and other institutional investors own 76.47% of the company's stock.
Insider Transactions at Allstate
In other news, Director Andrea Redmond sold 2,225 shares of the company's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the sale, the director owned 2,225 shares in the company, valued at approximately $451,474.75. This represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Mario Rizzo sold 56,225 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the transaction, the chief operating officer directly owned 82,227 shares in the company, valued at $21,747,396.96. The trade was a 40.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 91,446 shares of company stock valued at $24,208,675. Insiders own 1.55% of the company's stock.
Allstate Price Performance
ALL stock opened at $262.08 on Thursday. The stock's 50 day moving average is $252.60 and its two-hundred day moving average is $226.21. The Allstate Corporation has a 52-week low of $188.08 and a 52-week high of $277.22. The company has a market capitalization of $66.27 billion, a PE ratio of 5.23, a P/E/G ratio of 0.39 and a beta of 0.16. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, topping analysts' consensus estimates of $6.06 by $2.93. The business had revenue of $18.60 billion during the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business's quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.94 earnings per share. Analysts predict that The Allstate Corporation will post 34.45 earnings per share for the current fiscal year.
Allstate Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be given a $1.08 dividend. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 annualized dividend and a dividend yield of 1.6%. Allstate's payout ratio is presently 8.63%.
Analyst Ratings Changes
A number of analysts recently commented on ALL shares. HSBC lowered Allstate from a "buy" rating to a "hold" rating and increased their price objective for the company from $244.00 to $264.00 in a research note on Monday, July 6th. JPMorgan Chase & Co. upped their target price on shares of Allstate from $282.00 to $292.00 and gave the company an "overweight" rating in a report on Tuesday, August 11th. Raymond James Financial reaffirmed a "strong-buy" rating and set a $315.00 price target on shares of Allstate in a research note on Tuesday, August 11th. UBS Group boosted their price objective on shares of Allstate from $261.00 to $275.00 and gave the company a "neutral" rating in a research report on Monday, August 10th. Finally, Roth Capital set a $300.00 price objective on shares of Allstate in a research note on Thursday, August 6th. Four analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, Allstate has a consensus rating of "Hold" and an average price target of $265.26.
View Our Latest Research Report on Allstate
About Allstate
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Articles
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.